Vial Announces the Addition of Dr. Veeral Sheth of the University Retina and Macula Associates and the University of Illinois, Chicago, to their Ophthalmology CRO Scientific Advisory Board

SAN FRANCISCO, Dec. 13, 2022 /PRNewswire/ -- Vial, a global tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Veeral Sheth, MD, MBA, to Vial's scientific advisory board (SAB). Dr. Sheth will work closely with the company's leadership...

Click to view original post